OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 70 filers reported holding OCULAR THERAPEUTIX INC in Q2 2019. The put-call ratio across all filers is 1.35 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1 | 0.0% | 262 | 0.0% | 0.00% | – |
| Q2 2023 | $1 | 0.0% | 262 | 0.0% | 0.00% | – |
| Q1 2023 | $1 | 0.0% | 262 | 0.0% | 0.00% | – |
| Q4 2022 | $1 | -99.9% | 262 | 0.0% | 0.00% | – |
| Q3 2022 | $1,000 | 0.0% | 262 | 0.0% | 0.00% | – |
| Q2 2022 | $1,000 | 0.0% | 262 | 0.0% | 0.00% | – |
| Q1 2022 | $1,000 | -50.0% | 262 | 0.0% | 0.00% | – |
| Q4 2021 | $2,000 | -33.3% | 262 | 0.0% | 0.00% | – |
| Q3 2021 | $3,000 | +50.0% | 262 | +95.5% | 0.00% | – |
| Q2 2021 | $2,000 | 0.0% | 134 | 0.0% | 0.00% | – |
| Q1 2021 | $2,000 | -33.3% | 134 | 0.0% | 0.00% | – |
| Q4 2020 | $3,000 | +200.0% | 134 | -50.0% | 0.00% | – |
| Q3 2019 | $1,000 | 0.0% | 268 | 0.0% | 0.00% | – |
| Q2 2019 | $1,000 | 0.0% | 268 | 0.0% | 0.00% | – |
| Q1 2019 | $1,000 | – | 268 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SUMMER ROAD LLC | 5,944,761 | $23,898,000 | 100.00% |
| Opaleye Management Inc. | 5,974,800 | $24,019,000 | 10.83% |
| DELTEC ASSET MANAGEMENT LLC | 2,069,313 | $8,319,000 | 1.95% |
| Kamunting Street Capital Management, L.P. | 275,506 | $1,108,000 | 1.50% |
| Altium Capital Management LP | 695,000 | $2,794,000 | 1.12% |
| Endurant Capital Management LP | 760,228 | $3,056,000 | 1.07% |
| EMERALD ADVISERS, LLC | 1,465,702 | $5,892,000 | 0.30% |
| MSD Partners, L.P. | 1,016,302 | $4,086,000 | 0.25% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 1,044,732 | $4,200,000 | 0.24% |
| NOTTINGHAM ADVISORS, INC. | 194,266 | $781,000 | 0.11% |